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23 Abstract
24 Rapid and high quality preparation of peripheral blood leucocytes (PBL) is important in fish 
25 immunology research and in particular for fish vaccine development, where multiple immune 
26 parameters can be monitored on the same fish over time. Fish PBL are currently prepared by density 
27 separation using Percoll or Hispaque-1.077, which is time consuming, costly and prone to erythrocyte 
28 contamination. We present here a modified PBL preparation method that includes a 20 seconds 
29 hypotonic lysis of erythrocytes and a subsequent separation of PBL from cell debris by a cell strainer. 
30 This method is simple, rapid and cost effective. The PBL obtained are similar in cellular composition 
31 to those prepared by density separation but have less erythrocyte contamination as demonstrated by 
32 FACS analysis and the expression of cell marker genes. Marker gene analysis also suggested that PBL 
33 prepared by hypotonic lysis are superior to those obtained by the gradient method in that some high-
34 density cells (certain B cell types and neutrophils) might be lost using the latter. The PBL prepared in 
35 this way can proliferate in response to the T cell mitogen PHA, and both lymphoid and myeloid cells 
36 can phagocytose fluorescent beads and bacteria, with the latter enhanced by treatment with pro-
37 inflammatory cytokines (IL-1β and IL-6). Furthermore, the PBL can respond to stimulation with 
38 PAMPs (LPS, poly I:C) and cytokines (IL-1β and IFNγ) in terms of upregulation of proinflammatory 
39 cytokine gene expression. Such data demonstrate the utility of this approach (hypotonic lysis of 
40 erythrocytes) for PBL isolation and will enable more studies of their role in disease protection in future 
41 immunological and vaccine development research in fish.
42
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48 Fish immunology research has attracted much interest in recent years for theoretical and practical 
49 reasons. Fish immune systems provide important comparative outgroups for understanding the 
50 evolution of disease resistance. As a large vertebrate group, fish may have evolved novel mechanisms 
51 to tackle infections, and research into their responses should eventually lead to an increased 
52 understanding of the general principles of immune system adaptability in vertebrates (Feng et al., 2015; 
53 Flajnik, 2018). At the same time, the expanding aquaculture industry and associated disease risks 
54 requires fish immunology research to identify ways to manipulate the immune response and allow 
55 development of novel/ efficacious vaccines (Secombes, 2008; Van Muiswinkel, 2008; Lafferty et al., 
56 2015; Little et al., 2016). From a functional perspective, this research needs methods to rapidly prepare 
57 leucocytes from immune tissues such as head kidney, spleen and blood that are rich in erythrocytes. 
58 Peripheral blood leucocytes (PBL) are particularly relevant to vaccine development work, since samples 
59 can be obtained multiple times from the same individual during an immune response without killing the 
60 fish.
61
62 Classically, mammalian PBL have been purified by lysis of the non-nucleated erythrocytes that they 
63 possess with hypotonic ammonium chloride solutions that are commercially available. However, teleost 
64 erythrocytes are nucleated and resistant to ammonium chloride lysis (Rowley, 1990). Fish PBL have 
65 been routinely prepared by continuous or discontinuous density gradient centrifugation through 
66 separation media such as Percoll and Histopaque (Reitan and Thuvander, 1991; Korytar et al, 2013; 
67 Maisey et al., 2016; Takizawa et al., 2016, Zhang et al., 2017). Density gradient preparation of 
68 leucocytes is time consuming, expensive, and prone to erythrocyte contamination. Crippen et al (2001) 
69 reported a simple, rapid and inexpensive leucocyte purification method by hypotonic lysis of 
70 erythrocytes. In their method, blood was diluted (1:2) and erythrocytes lysed in a hypotonic solution by 
71 addition of distilled water for 20-40 seconds (s). The osmotic pressure was then brought back to 
72 isotonicity by addition of 10x phosphate-buffered saline (PBS). The cell suspension was centrifuged 
73 (750 g, 10 min) leaving a viscous mass containing cell debris and nuclear material on top of the cells, 
74 that could be removed and discarded. Whilst the resultant PBL were comparable to PBL prepared by 
75 gradient methods (Crippen et al., 2001), this method has not gained popularity in fish immunology 
76 research. This is partly due to the difficulty in separating the PBL from a viscous mass of cell debris 
77 and nuclear material in their method, and partly the lack of demonstrated functionality of the PBL 
78 prepared. 
79
80 We report here an improved hypotonic method to prepare leucocytes from fish blood using rainbow 
81 trout as a model. The blood was collected from the caudal vein and erythrocytes lysed by direct addition 
82 of cold water for 20 s (i.e. without dilution). 10x PBS was then added and the resultant PBL preparation 
83 kept on ice for 5-10 min to allow cell debris and nuclear material to clump and settle. The PBL are then 
84 easily separated from cell debris by passing through a cell strainer. The method is simple, rapid and 
85 inexpensive. The cell composition of the PBL isolated in this way is comparable to PBL prepared by 
86 use of density gradients and is free from erythrocyte contamination. Furthermore, we demonstrate that 
87 these PBL can proliferate, phagocytose and respond to pathogen associated molecular patterns 
88 (PAMPs) and cytokine stimulation.
89
90 2. Methods and Materials
91 2.1 Fish
92 Juvenile rainbow trout were purchased from College Mill Trout Farm (Perthshire, U.K.) and maintained 
93 in aerated fibreglass tanks supplied with a continuous flow of recirculating freshwater at 14 . Fish 
94 were fed twice daily on a commercial pellet diet (EWOS), and were reared to 200 - 500 g prior to use. 
95 All the experiments described comply with the Guidelines of the European Union Council 
96 (2010/63/EU) for the use of laboratory animals, and were carried out under UK Home Office project 
97 licence PPL 60/4013, approved by the ethics committee at the University of Aberdeen.
98
99 2.2. Peripheral blood leucocyte (PBL) preparation by hypotonic lysis of erythrocytes
100 The method for hypotonic lysis of erythrocytes was modified from that of Crippen et al. (2001). Dilution 
101 of blood was found to be unnecessary and so was omitted from the procedure, and a cell strainer was 
102 used to aid the separation of PBL from cell debris. The blood was drawn from the caudal vein using a 
103 BD Vacutainer Plus blood collection tube (with Lithium heparin, BD, UK). Premeasured HyPure cell 
104 culture grade water (36 ml, GE Healthcare Life Sciences, UK) and 10x PBS (4 ml, Sigma, UK) were 
105 cooled on ice. 4 ml of blood was transferred to a Falcon 50 mL conical centrifuge tube (or 15 mL tube 
106 for up to 1 ml blood). The erythrocytes were disrupted by combining the blood and ice-cold water and 
107 mixing by inversion for 20 s. The 10x PBS was then added to return the solution to isotonicity. The 
108 resultant PBL preparation was immediately put on ice for 5-10 min to allow the cell debris and nuclear 
109 materials to clump and settle to the bottom. The PBL were then separated from cell debris by passing 
110 through an EASYstrainer (70 μm, Greiner Bio One, UK), pelleted by centrifugation (200 g, 5 min), and 
111 washed once with incomplete cell culture medium (Leibovitz medium L-15, Life Technologies) 
112 supplemented with 100 IU/ml penicillin, 100 μg/ml streptomycin (P/S), and 1% foetal calf serum (FCS, 
113 Sigma, UK). The PBL were then resuspended in complete cell culture medium (as above except 10% 
114 FCS), and live cells counted using Trypan blue exclusion. A typical PBL preparation using 4 ml caudal 
115 vein blood resulted in 120-150 million PBL.
116
117 2.3. PBL preparation by gradient centrifugation using Histopaque-1077.
118 1 ml of blood obtained as above was diluted to 8 ml using 1x PBS and carefully layered onto 7 ml of 
119 Histopaque-1077  (Sigma, UK) in a 15 mL conical centrifuge tube, and centrifuged (without brake) at 
120 500 g for 40 min. The PBL were collected from the Histopaque interface, washed twice and counted as 
121 above. 
122
123 2.4. FACS analysis
124 Peripheral blood leucocytes were isolated as above and processed for flow cytometric analysis as 
125 follows. Prior to incubation with primary antibody a total of 5x105 cells per sample were blocked with 
126 PBS + 2% FCS (FACS buffer, FB) for 30 min at 4°C. The cells were then pelleted by centrifugation at 
127 250 g for 5 min and resuspended in 200 μl FB containing mouse anti-trout IgM (protein G-purified I-
128 14) (Deluca et al., 1983) and mouse anti-CD3ε (protein G-purified) (Maisey et al., 2016). Cells were 
129 incubated for 30 min at 4°C and then were washed with 800 μl FB. Cells were resuspended in FB (400 
130 μl) containing the secondary antibody (Alexa 647 donkey anti-mouse IgG, Molecular Probes). Cells 
131 were incubated for 30 min at 4°C, then washed with 800 μl FB and finally resuspended in 300 μl FB 
132 prior to analysis. For autofluorescence measurement, cells were resuspended with FB containing no 
133 antibody and for isotype controls, cells were treated only with the corresponding conjugated secondary 
134 antibody. Accuri C6 Flow Cytometer was used to analyse the samples, and at least 30,000 events were 
135 recorded for each sample. Flow cytometry analyses always included cell viability (propidium iodide) 
136 staining for exclusion of dead cells. Leucocytes exhibited a characteristic distribution in forward (FSC) 
137 and side scatter (SSC) allowing the distinction between the lymphoid (FSClowSSClow) and the myeloid 
138 cell population (FSChiSSChi). Doublets discrimination was performed in FSC-H/FSC-A and SSC-
139 H/SSC-A dot plots. Cells were analysed on a gate set on lymphocyte-sized cells. The gating procedure 
140 for cell analysis is shown in Supplementary Fig. S1. CFlow Plus software was used for the analysis.
141
142 2.5. Marker gene expression analysis
143 Freshly prepared PBL (107 cells) obtained by hypotonic lysis and Histopaque-1077, as described above, 
144 were used directly for total RNA preparation using TRI reagent (Sigma, UK). The cDNA synthesis and 
145 gene expression analysis by real-time PCR were as described previously (Wang et al., 2011a, 2016). 
146 Samples from whole blood were included for comparison. To prepare total RNA, 100 μl of whole blood 
147 were washed with 1.5 ml of PBS and centrifuged (400g, 5 min). The resultant cell pellet was dissolved 
148 in 1.5 ml TRI reagent. A variety of marker genes for T cells, B cells, neutrophils, monocytes/ 
149 macrophages, thrombocytes and erythrocytes were selected (Table 1) for expression analysis in PBL 
150 and whole blood. The primers (Table 2) were designed with at least one primer of each pair crossing 
151 an intron and tested to ensure that no genomic DNA could be amplified. The expression level was 
152 normalised to that of EF-1α and expressed as arbitrary units where the expression in whole blood was 
153 defined as 1 or 100.
154
155 2.6. Phagocytosis of PBL prepared by hypotonic lysis of erythrocytes
156 PBL in complete cell culture medium prepared as above (2×106 cells/ml) were added to 12-well 
157 suspension cell culture plates (Greiner bio-one, UK). Fluorescent latex beads (FluoSpheres Fluorescent 
158 Microspheres yellow green fluorescent, 1.0 um, Life technology) were added at a cell/bead ratio of 
159 1:20, and incubated at 20°C for 3 h. Both non-adherent and adherent cells were harvested using 0.5% 
160 trypsin-EDTA (GIBCO). Non-ingested beads were removed by centrifuging (100×g for 10 min at 4°C) 
161 over a 3% BSA and 4.5% D-glucose cushion prepared with FACS buffer (HBSS supplemented with 
162 2% FCS, 5 mM EDTA, and 0.1% sodium azide). Cells were washed with FACS buffer and analysed 
163 with a C6 Accuri Flow Cytometer, measuring at least 75,000 cells after live cell gating according to the 
164 FCS/SSC. 
165
166 For the effects of cytokine stimulation on phagocytosis, fresh PBL were stimulated with recombinant 
167 trout IL-1β (25 ng/ml, Hong et al., 2001), IL-6 (200 ng/ml, Costa et al., 2011), or medium alone as 
168 control. Fluorescent latex beads were added 20 h later at a cell/bead ratio of 1:20, incubated for a further 
169 3 h and phagocytosis analysed as above.
170
171 2.7. Proliferation of PBL prepared by hypotonic lysis of erythrocytes
172 PBL proliferation was quantified by measuring BrdU incorporation during DNA synthesis in replicating 
173 cells using a Cell Proliferation ELISA, BrdU (colorimetric) kit (Sigma, UK) as per the manufacturer’s 
174 instructions. Briefly, PBL from each fish in complete cell culture medium, at 4x105 cells/well, were 
175 cultured in 96-well cell culture plates in the presence of 2.5, 10 and 25 μg/ml of PHA. A control without 
176 PHA and a blank control without cells were also included. Three replicate wells were used for each 
177 treatment. The plates were then sealed and incubated at 20°C for 3 days. BrdU was added 20 h before 
178 fixation. The cell culture medium was removed after centrifugation (400 g, 5 min) and the cells fixed 
179 and DNA denatured by adding FixDenat solution. Anti-BrdU-peroxidase was then added and detected 
180 using tetramethylbenzidine. The colour reaction was read at 450 nm using an ELISA plate reader 
181 (SoftMax Pr0 5.3). To calculate a stimulation index, the average OD450 of triplicate wells from each 
182 fish was first subtracted from the background value (without cell blank control). A stimulation index 
183 was then calculated as the average of the resulting OD450 of PHA stimulated samples divided by that 
184 of untreated samples. 
185
186 2.8. Immune stimulation of PBL
187 Freshly prepared PBL obtained by hypotonic lysis of erythrocytes as above were seeded into 12-well 
188 cell culture plates (Greiner bio-one, UK) at 2x106 cells/ml, 2 ml/well, and stimulated with PAMPS and 
189 cytokines. These included polyinosinic: polycytidylic acid (Poly I:C, 50 μg/ml, Sigma, UK), 
190 lipopolysaccharide (LPS, 25 μg/ml, Sigma, UK), phytohemagglutinin from red kidney beans (PHA, 5 
191 μg/ml, Sigma, UK), recombinant IL-1β (25 ng/ml, Hong et al., 2001) and IFN-γ (20 ng/ml, Wang et al., 
192 20011b) for 4 h, 8 h and 24 h. The concentration chosen for each stimulant was deemed optimal for 
193 immune gene expression experiments based on our previous studies (Hong et al., 2001, 2013; Wang et 
194 al., 2011a, b). Real-time PCR quantification of the expression of a variety of cytokines (Table 2) was 
195 then undertaken as described above. The genes analysed included IL-1β1, IL-1β2 (Husain et al, 2012), 
196 TNFα1 (Laing et al., 2001), TNFα2 (Zou et al., 2003), TNFα3 (Hong et al., 2013), IL-6 (Costa et al., 
197 2011), IL-8 (Laing et al., 2002), IFNγ (Zou et al., 2005) and CXCL11_L1 (Chen et al., 2013). The 
198 results were expressed as a fold change relative to the time-matched unstimulated controls after 
199 normalising to EF-1α.  
200
201 2.9. Statistical analysis
202 The data were analysed statistically using the SPSS Statistics package 24.0 (SPSS Inc., Chicago, 
203 Illinois). Real-time PCR data were scaled, log2 transformed and used for statistical analysis as described 
204 previously (Wang et al., 2011a). The OD450 and percentage of cells were directly used for statistical 
205 analysis using a paired-sample T-test, with P <0.05 between groups considered significant.
206
207
208 3. Results and Discussion
209 3.1. The improved hypotonic method
210 PBL prepared by the hypotonic lysis of erythrocytes described above were free of red blood cell 
211 contamination, as determined by microscopy, and had >99.9% viability as assessed by trypan blue 
212 exclusion. The yield from healthy fish was ~30 x106 PBL/ml blood. The yield and viability of PBL 
213 prepared by the gradient method were similar but the preparations were typically contaminated with 
214 some red blood cells.
215 Compared to the method introduced by Crippen et al. (2001), our method firstly eliminated the dilution 
216 of blood, and this allows large volumes of blood to be processed easily. Secondly, our method used 
217 premeasured cold water and PBS (kept on ice on the day of use) that streamlined the procedure. We 
218 found that the removal of the viscous mass formed in Crippen’s method is difficult to perform reliably 
219 and leads to low yield or contamination with cell debris. Putting the erythrocyte lysed cell suspension 
220 on ice and letting the cell debris and nuclear materials clump and settle to the bottom of the tube 
221 overcomes this, and the PBL can be easily separated using a cell strainer. A 70 μm cell strainer has been 
222 routinely used for this purpose, although a 40 μm or 100 μm cell strainer can also be used. Clumping 
223 of cell debris and nuclear material may be affected by the low temperature in our procedure, and the 
224 use of undiluted blood that provides a larger amount of erythrocytes and hence more cell debris/ nuclear 
225 material. Therefore, there is no need for high force centrifugation (i.e. 750 g, 10 min) to pellet the 
226 viscous mass, as used in the original method, that may damage the cells. We found that 200g for 5 min 
227 was suffice to pellet the PBL in our procedure. 
228 The lysis time is important as the PBL may be irreversibly damaged if they spend too long in a hypotonic 
229 solution. It takes 2-3 s to close the lid after combining the blood and water, and 2 s to open the lid to 
230 add the 10xPBS. Thus if the total time of exposure to the hypotonic solution is 20 s this leaves 15 s for 
231 mixing by gentle inversion to completely lyse the erythrocytes. Longer time (eg. 40 s) for lysis is 
232 unnecessary. The PBL prepared using a 20 s lysis are of high quality as described later.
233
234 3.2. Characterisation of PBL prepared using the hypotonic and gradient method 
235 For flow cytometric analysis, PBL were prepared by the hypotonic lysis and gradient method 
236 simultaneously and compared side by side using each individual blood sample from six rainbow trout. 
237 Fig. S1 shows the gating analysis after PBL isolation. PBL prepared by both methods showed similar 
238 size and granularity characteristics of lymphocytes and granulocytes (Fig. 1A), as seen by Crippen et 
239 al. (2001). The cells had >97.5% viability as assessed by propidium iodide staining (Fig. 1B).
240 We further evaluated the B cell and T cell populations in the PBL using monoclonal antibodies against 
241 trout IgM and CD3ε respectively. No staining was observed in secondary antibody controls (Fig. 1C). 
242 The IgM antibody stained 31.4±7.7 % (Mean±SD) and 34.7±4.5 % leucocytes in the lymphocyte gate 
243 of PBL prepared by the hypotonic lysis and gradient method, respectively (Fig. 1D). Meanwhile the 
244 CD3ε antibody (as a T cell marker) stained 31.8±7.6 % and 32.7±7.6 % leucocytes in the lymphocyte 
245 gate (Fig. 1E). Paired samples T-test of the six fish analysed showed no significant difference in the 
246 percentages of IgM+ and CD3ε+ in the lymphocyte populations of the PBL prepared by both methods 
247 (Fig. 1F). IgM+ B cells and T cells with similar percentages have been recorded in rainbow trout PBL 
248 by Korytar et al. (2013).
249
250 3.3. Characterisation of cell marker gene expression in PBL prepared using the hypotonic lysis 
251 and gradient method
252 To complement the limited FACS analysis using antibodies, we analysed the expression of a large 
253 number of marker genes for different cell types present in PBL in whole blood and PBL prepared by 
254 the hypotonic lysis and gradient method (Table 1). 
255
256 3.3.1 Expression of marker genes for erythrocytes and proliferation
257 We first examined the expression of three genes, haemoglobin-a, haemoglobin-b and 5-aminolevulinate 
258 synthase erythroid (ALAS), specifically expressed in erythrocytes (Krasnov, et al., 2013). All these 
259 genes are highly expressed in whole blood samples but significantly reduce to less than 0.01% in PBL 
260 prepared by the hypotonic lysis method (Fig. S2A-C), suggesting efficient removal of erythrocytes. The 
261 expression of these genes was significantly higher in PBL prepared by the gradient method relative to 
262 the hypotonic method.
263 The head kidney and spleen are the main erythropoietic organs in fish, however peripheral blood can 
264 contain a high proportion of immature erythrocytes, mostly erythroblasts that divide and undergo their 
265 final maturation within the circulation (Witeska, 2013). In rainbow trout, 10.6% erythrocytes are 
266 immature (Keen, et al., 1989). In contrast, most peripheral blood leucocytes are mature and do not 
267 proliferate without stimulation. To examine whether signs of proliferation could be detected the 
268 expression of several proliferation markers, proliferation cell nuclear antigen (PCNA, Leung et al, 
269 2005), Ki63 and mini-chromosome maintenance protein (MCM)2 (Jurikova et al., 2016), were 
270 investigated. All of these proliferation marker genes had higher expression in whole blood compared to 
271 PBL prepared by both the hypotonic and gradient method, which were not different (Fig. S2D-F). These 
272 results confirm the removal of erythrocytes and the low proliferation level in PBL.
273
274 3.3.2 Expression of marker genes for T cells and B cells
275 The expression of lymphocyte markers for T cells (TCRα, TCRβ, CD3ε, CD3ζ, CD4-1, CD4-2, CD8α 
276 and CD8β) and B cells (CD79a, CD79b, secreted (s) IgM, membrane (m) IgM, sIgD, mIgD, sIgT and 
277 mIgT) were next examined (Fig. 2). The lymphocyte marker gene expression was consistently higher 
278 in PBL prepared by the hypotonic method compared to whole blood. Their expression in PBL prepared 
279 by the gradient method was also higher (CD3ζ, CD4-1, CD79a and mIgD), or showed intermediate 
280 levels that were not significantly different to the hypotonic prepared PBL or whole blood (TCRα, TCRβ, 
281 CD3ε, CD4-2, CD8α, CD8β, CD79b, sIgM, sIgT and mIgT). The exception was the expression of 
282 mIgM and sIgD where levels were not different to whole blood but lower than in hypotonic prepared 
283 PBL (Fig. 2). These expression patterns suggest that PBL prepared by the hypotonic method are 
284 enriched for both T cells and B cells due to complete removal of erythrocytes whilst PBL prepared by 
285 the gradient method are more prone to erythrocyte contamination and may lose some high-density B 
286 cells (Ramirez-Gomez, et al., 2012).
287
288 3.3.3 Expression of marker genes for other cell types
289 Other leucocyte markers examined were the pan leucocyte marker L plastin, pan myeloid marker Spi-
290 1a and Spi-1b, thrombocyte markers CD41 and G6F, neutrophil marker myeloperoxidase (MPO), 
291 macrophage markers lysozyme C and MCSFR and dendritic cell markers CD83 and CD80/86 (Table 
292 1). Expression of all the leucocyte marker genes was higher in PBL prepared by the hypotonic method 
293 compared to whole blood. Their expression in PBL prepared by the gradient method was also higher (L 
294 plastin and Spi-1b), or at intermediate levels that were not significantly different to PBL prepared by 
295 the hypotonic method or to whole blood (Spi-1a, CD41, MCSFR, lysozyme C, CD83 and CD86). The 
296 exception was the expression of G6F and the neutrophil marker MPO where levels were no different to 
297 whole blood but lower than in hypotonic prepared PBL (Fig. 3). These expression patterns suggest that 
298 PBL prepared by the hypotonic method are enriched for thrombocytes, neutrophils, macrophages and 
299 dendritic cells due to complete removal of erythrocytes and are potentially superior to PBL prepared by 
300 the gradient method that may lose some higher density cells such as neutrophils. 
301
302 3.4. Phagocytosis
303 Fish PBL contain B cells and other myeloid cells that are phagocytic (Takizawa et al., 2016; Zhang et 
304 al., 2017). The phagocytic potential of PBL prepared by the hypotonic method was analysed by flow 
305 cytometry using fluorescent beads (Fig. 4). 5.4% of the lymphoid cells were phagocytic in control PBL. 
306 This percentage was decreased to 4.5 by IL-1β treatment but not affected by IL-6 (Fig. 4D). The 
307 phagocytic lymphoid cells are presumably B cells (Zhang et al., 2017). Myeloid cells are more 
308 phagocytic, with 24.9% of these cells phagocytic in control PBL. This percentage was increased 
309 significantly to 45.3% and 29.2% by IL-1β and IL-6, respectively (Fig. 4D). The phagocytic myeloid 
310 cells showed a variety of granularities (Fig. 4C), suggesting different myeloid cells (eg neutrophils, 
311 macrophages and dendritic cells) might all contribute to the phagocytosis observed. The PBL prepared 
312 by the hypotonic method can also phagocytose bacteria, such as GFP expressing Aeromonas 
313 salmonicida and E. coli (data not shown). These results indicate that the PBL prepared by hypotonic 
314 lysis of erythrocytes are fully functional in terms of phagocytic capacity.
315
316 3.5. Proliferation of PBL prepared by the hypotonic lysis of erythrocytes
317 Most circulating PBL are non-proliferating mature cells as demonstrated by the low-level expression of 
318 proliferation marker genes (Fig. S2). They can be activated to proliferate by mitogens or vaccines, the 
319 latter a marker of antigen-mediated adaptive immune responses (Reitan and Thuvander, 1991). The 
320 proliferation potential of PBL prepared by the hypotonic method was demonstrated using PHA as a 
321 stimulant. BrdU incorporation was significantly increased in PBL treated with PHA from 2.5 to 25 
322 μg/ml (Fig. 5). Enhanced BrdU incorporation was also observed in PBL stimulated by a bacterin and 
323 recombinant trout cytokines (Wang et al., 2018). This result confirms the proliferation potential of PBL 
324 prepared by the hypotonic method. 
325
326 3.6. Immune response to PAMPs and pro-inflammatory cytokines of PBL prepared using the 
327 hypotonic lysis of erythrocytes 
328 The functionality of PBL prepared using the hypotonic method was further assessed by stimulating 
329 them with PAMPs (LPS, Poly I:C and PHA) and recombinant proinflammatory cytokines (IL-1β and 
330 IFNγ). The expression of all the pro-inflammatory cytokines (IL-1β1, IL-1β2, TNFα1, TNFα2, TNFα3, 
331 IL-6, and IL-8) was up regulated by all the PAMPs and rIL-1β at least at one time point, except TNFα1 
332 that was refractory to PHA (Fig. 6). IFNγ had no effect on the expression of IL-1β2, TNFα1, TNFα2, 
333 TNFα3, IL-6 and IL-8, but down-regulated IL-1β1 expression. IFNγ expression itself was up regulated 
334 by Poly I:C and PHA but was refractory to LPS, IL-1β and IFNγ (Fig. 6F). Lastly, CXCL11_L1 
335 expression was up regulated by Poly I:C, PHA and IFNγ from 4 h to 24 h, and by LPS at 8 h, but was 
336 refractory to IL-1β stimulation (Fig. 6I).  Gene-specific and stimulant-specific responses have also been 
337 seen previously using these stimulants and genes, suggesting that the PBL prepared by the hypotonic 
338 method are fully responsive and show typical responses.
339
340 3.7. General discussion and prospective
341 Rapid preparation of high quality PBL is highly desirable in fish immunology research and fish vaccine 
342 development. The density gradient method currently used is time consuming, costly and prone to 
343 erythrocyte contamination. Our modified PBL preparation method includes a 20 s hypotonic lysis of 
344 erythrocytes and a subsequent separation of PBL from cell debris by a cell strainer. This method is 
345 simple to perform, rapid and cost effective. The PBL obtained are free from erythrocyte contamination 
346 but have similar leucocyte composition to those prepared by density separation. The cell marker gene 
347 analysis suggested that PBL prepared by hypotonic lysis are superior in that certain cell markers were 
348 higher in these cells, suggesting some high-density cells (particularly B cells and neutrophils) might be 
349 lost by the gradient method. The PBL prepared using our hypotonic method can phagocytose, proliferate 
350 and respond to immune stimulants and cytokines. These data suggest that hypotonic lysis of 
351 erythrocytes is a rapid way to prepare high quality PBL that will enable more studies on PBL in disease 
352 and vaccine development research in fish.
353
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501 Table 1. Marker genes analysed in blood cell populations.
Gene Main population Other cell populations Reference
CD3ζ T cells Liu et al., 2008
CD3ε T cells Boardman et al., 2012
CD4-1 T cells Monocytes/macrophages Takizawa et al., 2016
CD4-2 T cells Monocytes/macrophages Takizawa et al., 2016
CD8α T cells Dendritic cells Takizawa et al., 2011, Kang 2012
CD8β T cells Moore et al., 2005
TCRα T cells Yazawa et al., 2008
TCRβ T cells Yazawa et al., 2008
sIgM H B cells Fillatreau et al., 2013
mIgM H B cells Fillatreau et al., 2013
sIgD H B cells Fillatreau et al., 2013
mIgD H B cells Fillatreau et al., 2013
sIgT H B cells Fillatreau et al., 2013
mIgT H B cells Fillatreau et al., 2013
CD79a B cells Liu et al., 2017
CD79b B cells Liu et al., 2017
Hemoglobin-a Erythrocytes Krasnov et al., 2013
Hemoglobin-b Erythrocytes Krasnov et al., 2013
ALAS Erythrocytes Krasnov et al., 2013
PCNA Proliferating cells
Leung et al., 2005; Juríková et al., 
2016
Ki67 Proliferating cells Juríková et al., 2016
MCM2 Proliferating cells Juríková et al., 2016
L plastin Leucocytes Hsu et al., 2004
Spi-1a Myeloid cells Immature lymphoid cells Hsu et al., 2004
Spi-1b Myeloid cells Immature lymphoid cells Hsu et al., 2004
CD41 Thrombocytes Lin et al., 2005
G6F Thrombocytes Ohashi et al., 2010
Myeloperoxidase 
(MPO) Neutrophils Other myeloid cells Lieschke et al., 2001
Lysozyme C Macrophages
Other myeloid 
cells/granulocytes Hall et al., 2007
MCSFR2 Macrophages Neural crest cells Zakrzewska et al., 2010
CD83 Dendritic cells T cells, B cells Aerts-Toegaert et al., 2007






507 Table 2.  Primers used for real-time PCR analysis.
508
Gene Sequence (5'-3') Sequence (5'-3') Size (bp) Acc. No.
Housekeeping gene
EF-1α CAAGGATATCCGTCGTGGCA ACAGCGAAACGACCAAGAGG 327 AF498320   
Cytokine genes
IL-1β1 CCTGGAGCATCATGGCGTG GCTGGAGAGTGCTGTGGAAGAACATATAG 179 AJ278242
IL-1β2 GAGCGCAGTGGAAGTGTTGG AGACAGGTTCAAATGCACTTTATGGT 204 AJ245925
TNFα1 TGTGTGGGGTCCTCTTAATAGCAGGTC CCTCAATTTCATCCTGCATCGTTGA 102 AJ277604
TNFα2 CTGTGTGGCGTTCTCTTAATAGCAGCTT CATTCCGTCCTGCATCGTTGC 98 AJ401377
TNFα3 GCTGCACTCTTCTTTACCAAGAAACAAG CCACTGAGGACTTGTAATCACCATAGGT 148 HE798544
IL-6 GGGAGAAAATGATCAAGATGCTCGT GCAGACATGCCTCCTTGTTGG 180 DQ866150              
IL-8 TCCTGACCATTACTGAGGGGATGA AGCGCTGACATCCAGACAAATCTC 200 AJ279069
IFNγ CAAACTGAAAGTCCACTATAAGATCTCCA TCCTGAATTTTCCCCTTGACATATTT 210 AJ616215
CXCL11_L1 TCATCAGCTTCCTGGCCTGTC TTCTCCGTTCTTCAGAGTGACAATGAT 191 AF396869
Marker genes
TCRα CAAACTGGTATTTTGACACAGATGCAA TTCTTGTGTTGTCTTTGAGGGACTGA 165/162 BT073987
TCRβ CAAAGTGGGGGAGAGATAACGACAGA TGTTTCTCTGAGGAGCCCTGGAA 149 AF329700
CD3ε AAGGAAAGGTGTGTAAGGACTGCTATG GAGCGGGAAGTGGGTTTTTG 160 NM_001195174 
CD3ζ CGTCTACTGCACTACCCTATGTCGAAG AAGTGTCGTCATTATTCCTGCGATTATC 273 BT073940
CD4-1 GTGTGGAGGTGCTACAGGTTTTTTC ATCGTCACCCGCTGTCTGTG 396 AY973028               
CD4-2 CGACATTGTCACAGTCAAGGTCC CCTCATTTGGCAACAAACTTCTCAC 284 AY973029
CD8α CAAGTCGTGCAAAGTGGGAAA TCTGTTGTTGGCTATAGGATGTTGTTG 214 AF178053
CD8β GAACTATCAAACCCCAGAAGGCTGTG GACACTTTTTGGGTAGTCGGCTGAA 125 AY563420
sIgM H TACAAGAGGGAGACCGGAGGAGT CTTCCTGATTGAATCTGGCTAGTGGT 221 X65261
mIgM H CCTACAAGAGGGAGACCGATTGTC GTCTTCATTTCACCTTGATGGCAGT 168 OMU04616 
sIgD H TGAACATATCCAAACCAGGTGTCTG GTCCTGAAGTCATCATTTTGTCTTGA 357 JQ003979
mIgD H TGAACATATCCAAACCAGAGCTCC GTCCTGAAGTCATCATTTTGTCTTGA 191 AY870260     
sIgT H CATCAGCTTCACCAAAGGAAGTGA TCACTTGTCTTCACATGAGTTACCCGT 361 AY870268  
mIgT H TCGAAGTCCACGGCGAACA GTGTTCTTCACCGCTTCATCTTGAA 187 AY870264
CD79a CGAGGGAATGTTACTGATGGTGG GCATTCCTCCAGATTTAGACCCTCATA 142 CA362887
CD79b CCTTTGTGAACCTCTCAGTGGC GGCCTTGTACCATTCCACCGT 238 XM_021565350
Hemoglobin-a GAGGCTTTGGGAAGGATGCTGAC CACAAGGATGTTGTGGGACAGAATCTT 170 EZ765953
Hemoglobin-b CACTGGCTCTGGGAAGAGTCCTGA TGAGGACGTCAGCCAACACCCT 186 FX112568
ALAS  CAGCCACATCATCCCAATAAAGGTTG           CACCTCCACGAGCCTCTCCAC 202 XM_021615925
PCNA GGGCACTGGCAACGTCAAAC TGTCAGCTATCTTGTACTCCACCACTAGGG 206 XM_021621842      
Ki67 GATGGGCGAGAGATTAATCAAATGTCA TGGCACTTGGGAAGCAAATCC 250 BT073583
MCM2 CGCAAAGAGTCCATGGCGAC TGAACAGCAGCAACTCATTGTTGTCTTT 253 XM_021610724      
L plastin CACAGATCAGCAGCTTCAAGGATAAGC GCTCCAATCTTCCTGGATACCGTGATA 178 XM_021571076      
Spi-1a AGTATGGCTCGTTACAGCGATGTTGA GGATCTTCTTCTTGTTGCCCAATTCTC 259 NM_001124513
Spi-1b CAGGCCCCTGTGTCCCCTAGTTA CGGATCTTCCTCTTGTTACCGGAGTC 149 XM_021578477
CD41 AAGTGGACAGGCTGAGACCCAGA GCGATTAAAGAACCCCACCTTCCA 68.6 157 XM_021624569
G6F  ACTGGGGACTTCTCTCTGCTGTTCA GGCTGAAGGAAAGATAGAGACTGTGAGGAC 141 GU393010
MPO TTTCGGTGACATGGCCAACAG TCCACACGAACATCACCTGCAAC 282 XM_021616849      
Lysozyme C AACAGCCTGCCCAACTGGGT ACACGCTTGGCACAACGGAT 227 XM_021601582
MCSFR GGACTTTGCCCCTCCAGAGATATACAC GATCACAATCCTCACTAATCTTAGCTTGGC 212 AB091826 
CD83 GTGAGGTGGTACAAGCTGGGTG GCTGCCAGGAGACACTTGTACCT 203 AY263797               




512 Figure 1. Flow cytometry detection of IgM+ and CD3ε+ lymphocytes in trout PBL prepared by 
513 the hypotonic lysis and gradient method. (A) Gate selection of isolated PBL. (B) Live cell gating by 
514 propidium iodide exclusion. (C) Secondary antibody control. (D) Percentages of IgM+ lymphocytes. 
515 (E) Percentages of CD3ε+ lymphocytes. (F) Mean + standard deviation of the percentages of IgM and 
516 CD3ε positive cells in PBL from six fish. The flow cytometry data (A-E) are for a representative fish 
517 of the 6 analysed.
518 Figure 2. The expression of T cell and B cell marker genes in whole blood, and PBL prepared by 
519 the hypotonic and gradient method. cDNA samples were prepared from whole blood (W), or PBL 
520 prepared by the hypotonic (H) and gradient (G) method from four fish. The expression of TCRα (A), 
521 TCRβ (B), CD3ε (C), CD3ζ (D), CD4-1 (E), CD4-2a (F), CD8α (G), CD8β (H), CD79a (I), CD79b (J), 
522 secreted (s) IgM (K), membrane (m) IgM (L), sIgD (M), mIgD (N), sIgT (O) and mIgT (P) was 
523 quantified by qPCR. The data are presented as mean (+SEM) arbitrary units where one unit equals the 
524 average expression level in whole blood. Different letters over the bars indicate significant differences 
525 (p<0.05, Paired samples T test).
526 Figure 3. The expression of other leucocyte marker genes in whole blood, and PBL prepared by 
527 the hypotonic and gradient method. cDNA samples were prepared from whole blood (W), or PBL 
528 prepared by the hypotonic (H) and gradient (G) method from four fish. The expression of L plastin (A), 
529 Spi-1 (B), Spi-2 (C), CD41 (D), G6F (E), MCSFR (F), lysozyme C (G), MPO (H), CD83 (I) and 
530 CD80/86 (J) was quantified by qPCR. The data are presented as mean (+SEM) arbitrary units, where 
531 one unit equals the average expression level in whole blood. Different letters over the bars indicate 
532 significant differences (p<0.05, Paired samples T test).
533 Figure 4. Flow cytometry analysis of phagocytosis. Trout PBL were incubated with IL-1β, IL-6 or 
534 medium alone as control for 20 h. PBL were then incubated with 1 μm fluorescent beads for 3 h and 
535 analysed by flow cytometry. Typical results from a single fish are shown in panels A-C. (A) Gating of 
536 lymphoid and myeloid cell populations. (B) Phagocytosis by cells in the lymphoid gate. (C) 
537 Phagocytosis by cells in the myeloid gate. (D) The percentage of phagocytic leucocytes in the lymphoid 
538 and myeloid gates. The results are presented as the mean (+ SEM) of four fish. Significant differences 
539 of paired sample T tests between stimulated and control samples is shown above the bars as * p ≤ 0.05. 
540 Figure 5. Rainbow trout PBL proliferation. Freshly prepared PBL from 4 fish were incubated with 
541 2.5, 10 and 25 μg/ml PHA, or with medium alone as control, in triplicate wells per fish, for 3 days. 
542 BrdU was added 20 h before incorporation of BrdU was detected by ELISA. The data are presented as 
543 the mean (+SEM) stimulation index, calculated as the OD450 of PHA treated cells divided by that of 
544 untreated samples. Significant differences of paired sample T tests between PHA-stimulated and control 
545 samples are shown above the bars as: * p ≤ 0.05.
546 Figure 6. Modulation of PBL cytokine gene expression by PAMPs and recombinant cytokines. 
547 Freshly prepared PBL were stimulated with LPS, Poly I:C, PHA, recombinant IL-1β and IFNγ for 4 h, 
548 8 h and 24 h. The expression of IL-1β1 (A), IL-1β2 (B), TNFα1 (C), TNFα2 (D), TNFα3 (E), IFNγ (F), 
549 IL-6 (G), IL-8 (H) and CXCL11_L1 (I) was quantified by real-time RT-PCR. Modulated expression 
550 was expressed as a fold change calculated as the mean expression level in stimulated cells normalized 
551 to that of time-matched controls. The means (+ SEM) of cells from four fish are shown. The relative 
552 significance of paired sample T tests between stimulated and time-matched control samples is shown 
553 above the bars as * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤0.001. 
554
555
556 Figure S1. Gating strategy for flow cytometric analysis. Examples for PBL purified by hypotonic 
557 lysis or the density gradient method. P1 = Leucocyte gate (A). P2 = Gate of excluded doublets in FSC-
558 H/FSC-A (B). P3 = Gate of excluded doublets in SSC-H/SSC-A (C). P4 = Live cells (as in Fig. 1B) and 
559 live lymphocytes gate (D). Leucocytes were recorded in P1 gate with P2, P3 and P4 gates excluded 
560 from counts (total of 30,000 events in P1).
561 Figure S2. The expression of erythrocyte and proliferation marker genes in whole blood, and PBL 
562 prepared by the hypotonic and gradient method. cDNA samples were prepared from whole blood 
563 (W), or PBL prepared by the hypotonic (H) and gradient (G) method from four fish. The expression of 
564 Hemoglobin-a (A), Hemoglobin-b (B), ALAS (C), PCNA (D), Ki67 (E) and MCM2 (F) was quantified 
565 by qPCR. The data are presented as mean (+SEM) arbitrary units, where 100 units equal the average 
566 expression level in whole blood. Different letters over the bars indicate significant differences (p<0.05, 
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